Endovia Health Sciences (EDVA) Total Debt Growth (3y) (2014 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Total Debt Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 0.08% |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | - |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 19.52% |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | 4.76% |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -22.30% |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | 210.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 210.69% |
| Mar 31, 2026 | 173.01% |
| Dec 31, 2025 | 3.72% |
| Sep 30, 2025 | 29.57% |
| Jun 30, 2025 | 32.03% |
| Mar 31, 2025 | -54.84% |
| Dec 31, 2024 | 70.21% |
| Sep 30, 2024 | 70.21% |
| Jun 30, 2024 | -58.28% |
| Mar 31, 2024 | -54.88% |
| Dec 31, 2023 | 67.94% |
| Sep 30, 2023 | -37.10% |
| Jun 30, 2023 | -32.31% |
| Mar 31, 2023 | -13.45% |
| Dec 31, 2022 | 22.13% |
| Sep 30, 2022 | 234.29% |
| Jun 30, 2022 | 177.02% |
| Mar 31, 2022 | 213.98% |
| Dec 31, 2021 | 241.65% |
| Sep 30, 2021 | 250.46% |